3 results match your criteria: "Dazhou College of Chinese Medicine[Affiliation]"
Diagnostic accuracy of transient elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: A meta-analysis.
World J Gastroenterol
January 2017
Ke Pu, Zhong-Qi Long, School of Clinical Medicine, Dazhou College of Chinese Medicine, Dazhou 635000, Sichuan Province, China.
Aim: To investigate the diagnostic accuracy of FibroScan (FS) in detecting esophageal varices (EV) in cirrhotic patients.
Methods: Through a systemic literature search of multiple databases, we reviewed 15 studies using endoscopy as a reference standard, with the data necessary to calculate pooled sensitivity (SEN) and specificity (SPE), positive and negative LR, diagnostic odds ratio (DOR) and area under receiver operating characteristics (AUROC). The quality of the studies was rated by the Quality Assessment of Diagnostic Accuracy studies-2 tool.
Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.
PLoS One
August 2016
DaZhou college of Chinese medicine, DaZhou, Sichuan Province, China.
Article Synopsis
- A meta-analysis was conducted to compare the effectiveness of intensity-modulated radiotherapy (IMRT) versus three-dimensional conformal radiotherapy (3DCRT) in treating non-small cell lung cancer (NSCLC).
- The study included 10 retrospective studies, evaluating overall survival (OS) and the risk of radiation-related side effects, specifically pneumonitis and esophagitis, with a focus on patient outcomes.
- The results showed that while IMRT and 3DCRT had similar overall survival rates, IMRT significantly reduced the risk of grade 2 radiation pneumonitis but increased the risk of grade 3 radiation esophagitis.
Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PLoS One
August 2016
Department of Cardiothoracic Surgery, Nanchong Central Hospital, Nanchong, China.
Article Synopsis
- A systematic review and meta-analysis was conducted to evaluate the effectiveness of gemcitabine and pemetrexed as maintenance treatments for non-small-cell lung carcinoma (NSCLC), focusing on recent studies.
- The analysis involved searching multiple databases and included data from eleven randomized controlled trials, assessing progression-free survival (PFS) and overall survival (OS) of the treatments against best supportive care (BSC) or placebo.
- Results showed that gemcitabine and pemetrexed significantly improved PFS compared to BSC, with pemetrexed also enhancing OS, while the combination with bevacizumab had some positive effects, but overall evidence quality varied from moderate to high.